258 related articles for article (PubMed ID: 36113315)
1. Hsa_circ_0008301 as a potential biomarker of disease activity for primary Sjogren's syndrome: Increased expression in peripheral blood of patients with primary Sjogren's syndrome.
Ji J; Zhang X; Ling Y; Tian J; Wang Y; Luo Y; Zhu R; Zhou Y; Zhu T; Wang L; Zhu H
Int Immunopharmacol; 2022 Nov; 112():109231. PubMed ID: 36113315
[TBL] [Abstract][Full Text] [Related]
2. The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome.
Zhu H; Wang Y; Wang G; Ling Y; Tian J; Zhou Y; Zhu R; Wang R; Wang R; Zhang W; Zhang X
Clin Rheumatol; 2024 Jun; ():. PubMed ID: 38866992
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA sequencing indicates circ-IQGAP2 and circ-ZC3H6 as noninvasive biomarkers of primary Sjögren's syndrome.
Li F; Liu Z; Zhang B; Jiang S; Wang Q; Du L; Xue H; Zhang Y; Jin M; Zhu X; Brown MA; Wu J; Wang X
Rheumatology (Oxford); 2020 Sep; 59(9):2603-2615. PubMed ID: 32250392
[TBL] [Abstract][Full Text] [Related]
4. CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.
Hong J; Cheng H; Wang P; Wu Y; Lu S; Zhou Y; Wang XB; Zhu X
Arthritis Res Ther; 2024 Jan; 26(1):26. PubMed ID: 38229121
[TBL] [Abstract][Full Text] [Related]
5. The proportion of CD161 on CD56
Zhao P; Yang Y; Song S; Cheng W; Peng C; Chang X; Wu J; Liu C
Immun Inflamm Dis; 2024 Apr; 12(4):e1244. PubMed ID: 38577997
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of circular RNA in primary Sjögren's syndrome.
Su LC; Xu WD; Liu XY; Fu L; Huang AF
Clin Rheumatol; 2019 Dec; 38(12):3425-3433. PubMed ID: 31420809
[TBL] [Abstract][Full Text] [Related]
7. Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren's Syndrome.
Chen Y; Chen Y; Zu B; Liu J; Sun L; Ding C; Wang D; Cheng X; Yang D; Niu G
J Immunol Res; 2020; 2020():9236234. PubMed ID: 33123604
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
9. [Early prediction of severe COVID-19 in patients with Sjögren's syndrome].
Li JB; Lyu MN; Chi Q; Peng YL; Liu PC; Wu R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1007-1012. PubMed ID: 38101781
[TBL] [Abstract][Full Text] [Related]
10. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
[TBL] [Abstract][Full Text] [Related]
11. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
[TBL] [Abstract][Full Text] [Related]
12. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
[TBL] [Abstract][Full Text] [Related]
13. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
Front Immunol; 2021; 12():670642. PubMed ID: 34248951
[TBL] [Abstract][Full Text] [Related]
14. Correlation of serum adenosine deaminase activity with disease activity in patients with primary Sjögren's syndrome.
Zhang H; Ye H; Xu Z; Dong K; Wang Y; Geng L; Wang S
Immunol Lett; 2023 Jun; 258():1-7. PubMed ID: 37127120
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of circular RNA hsa_circ_0079787 in the peripheral blood of patients with axial spondyloarthritis.
Luo Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
Mol Med Rep; 2020 Nov; 22(5):4197-4206. PubMed ID: 33000244
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.
Wang-Renault SF; Boudaoud S; Nocturne G; Roche E; Sigrist N; Daviaud C; Bugge Tinggaard A; Renault V; Deleuze JF; Mariette X; Tost J
Ann Rheum Dis; 2018 Jan; 77(1):133-140. PubMed ID: 28916716
[TBL] [Abstract][Full Text] [Related]
17. Increased METTL3 expression and m
Ma J; Wang X; Yang X; Wang X; Tan T; Fang H; Zhong Y; Zhang Q
BMC Ophthalmol; 2023 Jun; 23(1):252. PubMed ID: 37277716
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
[TBL] [Abstract][Full Text] [Related]
19. Retrospective screening of serum IgG glycosylation biomarker for primary Sjögren's syndrome using lectin microarray.
Li S; Zeng X; Tang S; Li X; Zhang G; Li M; Zeng X; Hu C
PeerJ; 2023; 11():e14853. PubMed ID: 36852221
[TBL] [Abstract][Full Text] [Related]
20. The association of Tyro3/Axl/Mer signaling with inflammatory response, disease activity in patients with primary Sjögren's syndrome.
Qin B; Wang J; Ma N; Yang M; Fu H; Liang Y; Huang F; Yang Z; Zhong R
Joint Bone Spine; 2015 Jul; 82(4):258-63. PubMed ID: 25881761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
